This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus.
A one-two punch of powerful antibodies may be the best way to stop Ebola virus, reports an international team of scientists in the journal Cell. Their findings suggest new therapies should disable Ebola virus’s infection machinery and spark the patient’s immune system to call in reinforcements.
“This study presents results from an unprecedented international collaboration and demonstrates how 43 previously competing labs can together accelerate therapeutics and vaccine design,” says Erica Ollmann Saphire, PhD, professor at Scripps Research and director of the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC).
From 2013–2016, West Africa faced the deadliest Ebola outbreak the world has ever seen. By the time the outbreak was declared over, 11,325 people had died. The VIC is an international group of the world’s leading virologists, immunologists, systems biologists and structural biologists working to stop an outbreak on that scale from ever striking again.
The VIC researchers aim to understand which Ebola-fighting antibodies are best—and why. The hope is that the most effective antibodies can be combined in a therapeutic “cocktail.” Unlike an Ebola vaccine, these cocktails could be given to those already infected, which is important for stopping a disease that tends to emerge unexpectedly in remote locations.
Ollmann Saphire and her colleagues in the VIC have published more than 40 studies in just the last five years. This landmark study is the first-ever side-by-side comparison of 171 antibodies against Ebola virus and other related viruses, known as filoviruses. All antibodies in the panel were donated by different labs around the world, and many had not been previously characterized in such extensive detail.
“Through the VIC, we could test a larger pool of antibodies in parallel, which increased the potential to detect statistically significant relationships between antibody features and protection,” says Saphire. “We used this global pool of antibodies to evaluate, and streamline, the research pipeline itself.”
In addition to identifying links between antibody target locations and activity, VIC researchers tested this huge pool of antibodies to reveal which antibodies “neutralized” the virus, why neutralization assays so often disagree, and whether or not neutralization in test tubes adequately predicted how well these antibodies would protect live animals from Ebola virus infection. Unexpectedly, neutralization alone was not always associated with the protective ability of an antibody.
Notably, the scientists found nine antibodies that protected mice from infection without neutralizing the virus in test tubes. These antibodies likely fight infection by interacting with an infected person’s immune system, helping orchestrate a better immune response to the virus.
This “immune effector” activity is featured in the team’s companion study published simultaneously in Cell Host & Microbe. “The ability to evoke an immune response will likely represent a new avenue of study for therapeutic antibodies for Ebola virus infection,” says Sharon Schendel, project manager for the VIC and science writer in the Saphire lab.
From the large body of results, VIC member and Scripps Research faculty member Kristian Andersen, PhD, and his graduate student Karthik Gangavarapu developed a network describing how each antibody feature correlates to protection, which can serve as a guide to predict whether newly identified antibodies will have therapeutic value. Saphire says the next steps for the VIC are to further test promising antibody cocktails in non-human primates. The team will also pursue engineering of antibodies that carry signature features to better drive immune system response.
The Latest on: Ebola
via Google News
The Latest on: Ebola
- Ebola survivors turn caregivers in Congo outbreak on April 17, 2019 at 6:11 am
Wearing only scrubs and a hair net, Jeanine Masika cradles a two-year-old Ebola patient in her arms. Masika has antibodies in her system after she won her own battle against Ebola last year, and she ... […]
- Congo-Kinshasa: Following Second Brutal Assault On Ebola Clinic, UN Health Chief Vows to Continue Serving 'Most Vulnerable' on April 17, 2019 at 4:59 am
Amidst a deadly Ebola outbreak, on Saturday morning armed militia members brutally attacked an Ebola clinic in the Democratic Republic of the Congo's (DRC) eastern city of Butembo, prompting a ... […]
- WHO Emergency Committee expresses ‘deep concern’ about Ebola risk on April 17, 2019 at 1:25 am
A recent meeting of a WHO Emergency Committee convened to consider the Ebola outbreak in the Democratic Republic of the Congo has concluded that there is an increasing risk of spread to adjoining ... […]
- Democratic Republic of Congo: Ebola Virus Disease - External Situation Report 37 on April 16, 2019 at 5:34 pm
This past week saw the continued rise in the number of Ebola virus disease (EVD) cases in the North Kivu and Ituri provinces of the Democratic Republic of the Congo, with a total of 110 new ... […]
- Ebola is real, Congo president tells skeptical population on April 16, 2019 at 3:52 pm
GOMA, Democratic Republic of Congo (Reuters) - Congolese President Felix Tshisekedi on Tuesday implored people in areas hit by the nation’s worst-ever Ebola outbreak to accept the disease is real and ... […]
- FP Honored for Selfless Service in Ebola-ravaged Liberia on April 16, 2019 at 3:40 pm
As of April 14, 1,264 confirmed/probable cases of Ebola virus disease (EVD) in the Democratic Republic of the Congo have been reported to the World Health Organization,(www.who.int) as well as 814 ... […]
- Congo's leader sets Ebola outbreak end date after 800 deaths on April 16, 2019 at 2:49 pm
Congos president said Tuesday that he wants an Ebola virus outbreak that already has become the countrys second-deadliest contained in less than three months, although some health experts estimate ... […]
- Congo’s president wants Ebola contained within 3 months on April 16, 2019 at 11:10 am
BENI, Congo — Congo’s president says he wants to see a deadly Ebola virus outbreak contained in less than three months even as some health experts say it could take twice as long. President Felix ... […]
- Study: Many in Ebola outbreak don’t believe virus is real on March 27, 2019 at 5:47 pm
DAKAR, Senegal — One out of four people interviewed in eastern Congo last year believed Ebola wasn’t real, according to a new study, underscoring the enormous challenges health care workers are facing ... […]
via Bing News